Semaglutide vs Tirzepatide: Which Is Right for You?
Two medications. One goal. But they are not the same — and choosing between them is a clinical decision, not a preference.
Compounded semaglutide and compounded tirzepatide are both GLP-1 receptor agonists, both proven to produce meaningful, sustained weight loss, and both available through our practice at Evolution Health. What differs is how they work, how patients typically respond, and which is likely to be the better fit for your specific physiology.
Here is what the science shows — and how we think about this decision with our patients.
HOW BOTH MEDICATIONS WORK
GLP-1 receptor agonists mimic a naturally occurring gut hormone called glucagon-like peptide-1. This hormone signals to the brain that you have eaten, slows the rate at which your stomach empties, and plays a direct role in blood sugar regulation by stimulating insulin release.
When this system is functioning poorly — which is common in patients with metabolic dysfunction, insulin resistance, or hormonal imbalance — appetite regulation breaks down and weight gain accelerates despite genuine dietary effort.
Both semaglutide and tirzepatide restore this signaling at therapeutic levels. The meaningful difference lies in tirzepatide’s additional mechanism.
SEMAGLUTIDE: SINGLE-RECEPTOR, ESTABLISHED RECORD
Compounded semaglutide targets the GLP-1 receptor specifically. It has the longest clinical track record among this class of medications, with outcome data spanning multiple years and patient populations.
For the majority of patients beginning GLP-1 therapy, compounded semaglutide is an effective and well-characterized starting point. Patients typically experience meaningful appetite reduction within two to four weeks of initiating therapy, with weight loss accelerating as dosing is titrated upward over the first several months.
Semaglutide is administered by weekly subcutaneous injection, which patients self-administer after training.
TIRZEPATIDE: DUAL-RECEPTOR, STRONGER METABOLIC EFFECT
Compounded tirzepatide targets two receptors — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The dual-receptor action produces a more pronounced effect on insulin sensitivity and, in clinical data, generally greater total weight reduction compared to single-receptor agents at equivalent stages of therapy.
For patients with significant insulin resistance, elevated fasting glucose, or those who have plateaued on semaglutide, tirzepatide often produces a stronger metabolic response.
Like semaglutide, tirzepatide is administered by weekly subcutaneous injection.
HOW WE DECIDE WHICH IS RIGHT FOR YOU
The choice between compounded semaglutide and compounded tirzepatide is not made based on what a patient has heard about, what they saw online, or what produced results for a friend. It is made based on a complete clinical evaluation.
Our team of two board-certified ARNPs reviews your lab work, metabolic markers, current medications, and full health history before recommending a medication. Factors that inform the decision include your degree of insulin resistance, your history with weight loss attempts, any existing metabolic conditions, and how your body has responded to prior interventions.
In some cases, starting with semaglutide and transitioning to tirzepatide after an initial evaluation period is the right approach. In others, beginning with tirzepatide is clinically indicated from the start.
There is no universal answer — which is exactly why this decision belongs in a clinical conversation, not a comparison article.
WHO IS A CANDIDATE
Both medications are appropriate for adults with a BMI of 30 or above, or 27 or above with a weight-related comorbidity. Both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
A thorough evaluation at your appointment will confirm whether either medication is appropriate for your situation and which is likely to produce the best outcome.
WHAT WE DO AT EVOLUTION HEALTH
We serve patients in Centralia, Chehalis, and Olympia in person, and across Washington State and Oregon via telehealth. Every patient who begins GLP-1 therapy at Evolution Health receives an individualized dosing plan, proactive side-effect management, and regular clinical check-ins — not a prescription and a handshake.
The medication works. The supervision is what makes the results last.
Book your appointment at evolutionhealthllc.com
FREQUENTLY ASKED QUESTIONS
Q: Can I request tirzepatide specifically if I have heard it produces better results? A: You can absolutely share your preference during your appointment. Our providers will evaluate whether tirzepatide is clinically appropriate for you and explain their reasoning. Patient input matters — and so does clinical judgment.
Q: What side effects should I expect? A: The most common side effects for both medications are gastrointestinal — nausea, mild bloating, or changes in bowel habits — particularly during dose titration. Most patients find these manageable and temporary. Our team actively monitors and adjusts dosing to minimize side effects.
Q: How long will I be on one of these medications? A: Duration is individualized. Some patients use GLP-1 therapy as a long-term metabolic support tool. Others reach their goal weight and transition to a supervised maintenance plan. We do not encourage stopping without a clinical tapering strategy in place.
Q: Is one medication significantly more expensive than the other? A: Costs vary by pharmacy and compounding specifications. We provide transparent pricing information at your appointment and discuss what is covered under any applicable insurance or self-pay arrangements.
WRITTEN BY Debra Gross, ARNP — Board-Certified Acute Care Nurse Practitioner, 22+ years clinical experience Ellen Gish, ARNP — Board-Certified Nurse Practitioner Evolution Health LLC | Centralia, WA | evolutionhealthllc.com
Medical Disclaimer: The information in this post is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication or treatment plan.
